Molecular aspects of cancer cell resistance to chemotherapy

被引:340
作者
Rebucci, Magali [1 ]
Michiels, Carine [1 ]
机构
[1] Univ Namur FUNDP, URBC NARILIS, Namur, Belgium
关键词
Cancer; Resistance; Anti-cancer agents; Targeted therapies; Hypoxia; Cancer stem cells; DNA-DAMAGE RESPONSE; MEDIATED DRUG-RESISTANCE; MULTIDRUG-RESISTANCE; BREAST-CANCER; TUMOR MICROENVIRONMENT; STEM-CELLS; SIGNALING PATHWAYS; CHEMORESISTANCE; MECHANISMS; P53;
D O I
10.1016/j.bcp.2013.02.017
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cancer cell resistance to chemotherapy is still a heavy burden that impairs treatment of cancer patients. Both intrinsic and acquired resistance results from the numerous genetic and epigenetic changes occurring in cancer cells. Most of the hallmarks of cancer cells provide general mechanisms to sustain stresses such as the ones induced by chemotherapeutic drugs. Moreover, specific changes in the target bring resistance to specific drugs like modification in nucleotide synthesis enzymes upon anti-metabolite exposure, in microtubule composition upon spindle poison treatment, in topoisomerase activity upon topoisomerase inhibitor incubation or in intracellular signaling pathways when targeting tyrosine kinase receptors. Finally, the stemness properties of a few cancer cells as well as components of the tumor stroma, like fibroblasts and tumor-associated macrophages but also hypoxia, also help tumor to resist to anticancer agents. These processes provide an additional level of complexity to the understanding of the tumor resistance phenomenon. This review aims to describe the different general mechanisms as well as some examples of specific on target modifications inducing cancer cell resistance to chemotherapy at the molecular level. Perspectives to develop more efficient treatment, using genomic signature or more specific biomarkers to characterize putative resistance mechanisms in patients before choosing the more appropriate treatment, will also be discussed. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:1219 / 1226
页数:8
相关论文
共 100 条
[1]   Poly (ADP-Ribose) Polymerase as a Novel Therapeutic Target in Cancer [J].
Annunziata, Christina M. ;
O'Shaughnessy, Joyce .
CLINICAL CANCER RESEARCH, 2010, 16 (18) :4517-4526
[2]   Non-Peptidic Small Molecule Inhibitors Against Bcl-2 for Cancer Therapy [J].
Azmi, Asfar S. ;
Mohammad, Ramzi M. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2009, 218 (01) :13-21
[3]   Dihydropyrimidine dehydrogenase and thymidylate synthase activities in hepatocellular carcinomas and in diseased livers [J].
Baba, H ;
Teramoto, K ;
Kawamura, T ;
Mori, A ;
Imamura, M ;
Arii, S .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (06) :469-476
[4]   The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity [J].
Barretina, Jordi ;
Caponigro, Giordano ;
Stransky, Nicolas ;
Venkatesan, Kavitha ;
Margolin, Adam A. ;
Kim, Sungjoon ;
Wilson, Christopher J. ;
Lehar, Joseph ;
Kryukov, Gregory V. ;
Sonkin, Dmitriy ;
Reddy, Anupama ;
Liu, Manway ;
Murray, Lauren ;
Berger, Michael F. ;
Monahan, John E. ;
Morais, Paula ;
Meltzer, Jodi ;
Korejwa, Adam ;
Jane-Valbuena, Judit ;
Mapa, Felipa A. ;
Thibault, Joseph ;
Bric-Furlong, Eva ;
Raman, Pichai ;
Shipway, Aaron ;
Engels, Ingo H. ;
Cheng, Jill ;
Yu, Guoying K. ;
Yu, Jianjun ;
Aspesi, Peter, Jr. ;
de Silva, Melanie ;
Jagtap, Kalpana ;
Jones, Michael D. ;
Wang, Li ;
Hatton, Charles ;
Palescandolo, Emanuele ;
Gupta, Supriya ;
Mahan, Scott ;
Sougnez, Carrie ;
Onofrio, Robert C. ;
Liefeld, Ted ;
MacConaill, Laura ;
Winckler, Wendy ;
Reich, Michael ;
Li, Nanxin ;
Mesirov, Jill P. ;
Gabriel, Stacey B. ;
Getz, Gad ;
Ardlie, Kristin ;
Chan, Vivien ;
Myer, Vic E. .
NATURE, 2012, 483 (7391) :603-607
[5]   Targeting the DNA damage response in oncology: past, present and future perspectives [J].
Basu, Bristi ;
Yap, Timothy A. ;
Molife, L. Rhoda ;
de Bono, Johann S. .
CURRENT OPINION IN ONCOLOGY, 2012, 24 (03) :316-324
[6]  
BATRA SK, 1995, CELL GROWTH DIFFER, V6, P1251
[7]   Chemoresistance of glioblastoma cancer stem cells - much more complex than expected [J].
Beier, Dagmar ;
Schulz, Joerg B. ;
Beier, Christoph P. .
MOLECULAR CANCER, 2011, 10
[8]   Targeting hypoxic tumour cells to overcome metastasis [J].
Bennewith, Kevin L. ;
Dedhar, Shoukat .
BMC CANCER, 2011, 11
[9]   HYPOXIA AND METABOLISM SERIES - TIMELINE The impact of O2 availability on human cancer [J].
Bertout, Jessica A. ;
Patel, Shetal A. ;
Simon, M. Celeste .
NATURE REVIEWS CANCER, 2008, 8 (12) :967-975
[10]   Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what? [J].
Borst, Piet .
OPEN BIOLOGY, 2012, 2